DERMBIONT, INC.

Profile

Company Names

DERMBIONT, INC.

Addresses

75 KNEELAND ST FL 14, BOSTON, MA 02111

75 KNEELAND ST. FL. 14, BOSTON, MA 02111

451 D STREET, SUITE 908, BOSTON, MA 02210

451 D STREET, SUITE 908, BOSTON, MA 02210

451 D STREET, 9TH FLOOR, SUITE 908, BOSTON, MA 02210

75 KNEELAND STREET, 14TH FLOOR, BOSTON, MA 02111

75 KNEELAND STREET, 14TH FLOOR, BOSTON, MA 02111

Phone Numbers

510-607-8155
781-929-5098

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$114,164,089.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2023-10-04 
$32,697,081.00 
$45,312,683.00 
$12,615,602.00 
Equity 
9
2023-03-06 
$4,693,564.00 
$4,693,564.00 
$0.00 
Debt 
8
2022-09-06 
$2,514,010.00 
INDEFINITE 
INDEFINITE 
Debt 
7
2021-12-30 
$830,267.00 
$830,267.00 
$0.00 
Equity 
6
2021-12-17 
$28,845,632.00 
$39,520,131.00 
$10,674,499.00 
Equity 
5
2021-08-04 
$19,171,591.00 
$19,171,591.00 
$0.00 
Equity 
4
2021-02-12 
$6,550,582.00 
$15,000,000.00 
$8,449,418.00 
Debt 
3
2020-10-16 
$7,200,004.00 
$8,000,000.00 
$799,996.00 
Equity 
2
2020-02-19 
$2,871,893.00 
$6,000,000.00 
$3,128,107.00 
Debt 
1
2019-05-31 
$8,789,465.00 
$8,789,465.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN 
 
BASTA 
DIRECTOR
CARBYLAN BIOSURGERY, INC   |  VIVEVE MEDICAL, INC.   |  DERMBIONT, INC.   |  VYNE THERAPEUTICS INC.
KARL 
R 
BEUTNER 
EXECUTIVE OFFICER, DIRECTOR
DERMBIONT, INC.
KARL 
R. 
BEUTNER 
EXECUTIVE OFFICER, DIRECTOR
DERMBIONT, INC.
ROBERT 
 
BRUCKER 
EXECUTIVE OFFICER
DERMBIONT, INC.
MAX 
 
DAWSON 
EXECUTIVE OFFICER
DERMBIONT, INC.   |  RINASCERA THERAPEUTICS, INC.
NICHOLA 
 
ELIOVITS 
EXECUTIVE OFFICER, DIRECTOR
SCRIPTDASH INC.   |  DERMBIONT, INC.   |  ALTO PHARMACY HOLDINGS, INC.   |  MENDEL HEALTH INC.   |  OT DST FUND I, LLC   |  OT PHARMA FUND VIII, LLC   |  OT MATERIALS FUND I, LLC   |  MAVERICK BIOMETALS INC.   |  OT HEALTHCARE FUND I, LLC   |  OT YC FUND IV, LLC   |  PHOENIX TAILINGS, INC.   |  OT PHARMA FUND IX, LLC   |  OT MATERIALS FUND II, LLC   |  RINASCERA THERAPEUTICS, INC.   |  OT AI INFRASTRUCTURE FUND I, LLC   |  OT QUANTUM FUND I, LLC   |  MAVERICK LABS, INC.   |  OT HEALTHCARE FUND III, LLC   |  OT ROBOTICS FUND I, LLC   |  OT AI CYBER FUND I, LLC
JENNIFER 
 
LEE 
DIRECTOR
DERMBIONT, INC.   |  T.Y.LIN INTERNATIONAL GROUP, LTD.   |  LEEGEN INVESTMENT LLC   |  K1X CO-INVEST, LLC   |  ADDITION THERAPEUTICS, INC.
WILDER 
 
RAMSEY 
DIRECTOR
CONVERSICA, INC.   |  GRON VENTURES FUND I, LP   |  DERMBIONT, INC.   |  GRON VENTURES FLORIDA, LP   |  COURIER PLUS, INC.   |  LUCID GREEN, INC.   |  GRON VENTURES FUND II, LP   |  HEADING HEALTH INC.
RAMSEY 
 
WILDER 
DIRECTOR
DERMBIONT, INC.
DANIEL 
 
YADEGAR 
DIRECTOR
NEWPATH PARTNERS, L.P.   |  DERMBIONT, INC.   |  RINASCERA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-11-13
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-04 
2023-10-19
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-04 
2023-10-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-04 
2023-03-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-03-06 
2022-09-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-09-06 
2022-01-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-30 
2021-12-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-17 
2021-08-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-04 
2021-02-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-02-12 
2020-10-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-16 
2020-03-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-02-19 
2019-06-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#